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Abstract
Background: Mitochondria-localized glutamic acid-rich protein (MGARP) is a novel mitochondrial transmembrane protein
expressed mainly in steroidogenic tissues and in the visual system. Previous studies showed that MGARP functions in
hormone biosynthesis and its expression is modulated by the HPG axis.
Methodology/Principal Findings: By bioinformatics, we identified two characteristic GC-rich motifs that are located
proximal to the transcription start site (TSS) of MGARP, and each contains two Specificity protein 1 (Sp1) binding elements.
We then determined that the 23 kb proximal MGARP promoter is activated in a Sp1-dependent manner using reporter
assays and knockdown of Sp1 led to decreased expression of endogenous MGARP messages. We also demonstrated that
one of the two GC-rich motifs, GC-Box1, harbors prominent promoter activity mediated by Sp1, and that it requires both GC
boxes for full transcriptional activation. These findings suggest a dominant role for these GC boxes and Sp1 in activating the
MGARP promoter through a synergistic mechanism. Consistently, the results of an Electrophoretic Mobility Gel Shift Assay
(EMSA) and Chromatin Immunoprecipitation (ChIP) confirmed that Sp1 specifically interacts with the GC-rich region. We
further found that estrogen receptor a (ERa), a known Sp1 co-activator, could potentiate GC-boxes containing MGARP
promoter activity and this effect is mediated by Sp1. Knockdown of Sp1 significantly diminished the MGARP promoter
transactivation and the expression of endogenous MGARP mediated by both Sp1 and ERa.
Conclusions/Significance: The present study identified a proximal core sequence in the MGARP promoter that is composed
of two enriched Sp1 binding motifs and established Sp1 as one major MGARP transactivator whose functions are synergistic
with ERa, providing a novel understanding of the mechanisms of MGARP gene transcriptional regulation.
Citation: Jin D, Li R, Mao D, Luo N, Wang Y, et al. (2012) Mitochondria-Localized Glutamic Acid-Rich Protein (MGARP) Gene Transcription Is Regulated by Sp1. PLoS
ONE 7(11): e50053. doi:10.1371/journal.pone.0050053
Editor: Bin He, Baylor College of Medicine, United States of America
Received January 26, 2012; Accepted October 15, 2012; Published November 27, 2012
Copyright:  2012 Jin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Natural Science Foundation of China (No.81171063 and 81072167) and the Tsinghua University
Initiative Scientific Research Program (No.2009THZ01005). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bczhang@tsinghua.edu.cn
Introduction
Mitochondria-localized glutamic acid-rich protein (MGARP)
was first identified in the ovary as the ovary-specific acidic protein
(OSAP) [1] and, thereafter, it was identified in the cornea [2] and
retina [3]. Since this protein is made up of abundant glutamic
acids and has specific mitochondrion localization, it was given a
universal name, MGARP [3]. Our previous studies have
demonstrated that MGARP is highly expressed in the inner
segment of the photoreceptor (IS), outer plexiform layer (OPL)
and ganglion cell layer (GCL) of the retina, which are enriched
with mitochondria [3]. Additional studies have indicated that
MGARP is involved in steroidogenesis through its ability to
maintain mitochondrial abundance and morphology, and impor-
tantly, it is also highly expressed in the organs involved in
steroidogenesis, such as the ovary, testis, adrenal gland and brain
[4,5]. MGARP can also be induced by HIF-1 and hypoxia, biasing
mitochondrial transport in the anterograde direction and joining
the mitochondrial dance [6,7]. Our recent study reported
temporal and tissue-specific expression patterns of MGARP
during mouse development [5]. The MGARP protein cannot be
detected in the ovary or testis until 2–4 weeks after birth, likely
depending on the availability of particular steroids [5]. Further-
more, MGARP expression correlates with estrogen levels in the
ovaries during the estrous cycle and it can be up-regulated by
estrogen and down-regulated by a GnRH antagonist through a
feedback regulatory mechanism [5].
Steroid hormones play pivotal functions in the animal body
throughout life. Their major physiological functions include the
regulation of behavior, mood, reproduction, development, sex
differences in brain function, aging, responses to the environmen-
tal stimuli and development of various diseases [8–11]. The
activity of steroid hormones is mediated by specific effectors such
as steroid receptors that function as ligand-activated transcription
factors [12,13]. Estrogens can bind to the estrogen receptor (ER)
and stimulate its translocation into the nucleus, where ERs bind to
chromatin via specific ER-regulated elements (ERE) to activate
downstream gene transcription [14,15]. It is also known that
transactivators, including steroid receptors and particularly ER,
depend on co-factors (co-activators versus co-repressors) for full
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co-factor for other transactivators [18].
As a well established general transcriptional factor, Sp1 interacts
with GC or GT boxes on the DNA backbone via its highly
homologous zinc-finger domain [18,19]. Its N-terminal glutamine-
and serine/threonine-rich domain can function as a transactivator,
and its C-terminus has a synergistic activation function through its
interaction with other transcription factors [20]. Sp1 is implicated
in a variety of biological processes, such as early embryonic
development, the G1 phase of the cell cycle, and importantly,
steroid receptor-mediated transcription [19,21,22]. Sp1 can
interact with ERa and contribute to transcriptional outcomes
[15,23–26].
As mentioned above, reports have documented that MGARP
participates in steroid synthesis, and steroids also regulate
MGARP expression [4,5]. However, the detailed regulatory
mechanisms of MGARP gene expression remain unknown. In
the present study, we have carried out a characterization study of
the MGARP promoter. Using bioinformatics, we identify two
classic Sp1-binding GC-rich motifs (2150 bp/240 bp and
239 bp/0 bp) proximal to the transcription start site (TSS). We
demonstrate that reporters driven by the MGARP promoters
containing the specific GC-rich motifs are activated by Sp1, and
are shown by EMSA and ChIP to also bind Sp1. We also
determine that ERa could further enhance the activity of the
MGARP promoter that is activated by endogenous or exogenous
Sp1 in a dominant manner. Collectively, our findings suggest a
Sp1 regulatory mechanism in MGARP transcriptional regulation,
with ERa functioning cooperatively with Sp1.
Materials and Methods
Plasmids and Reagents
The bioinformatics analysis was carried out as described in Text
S1. The bacterial artificial chromosome clone bearing the
MGARP gene (BAC, RP11-468C4) was purchased from Invitro-
gen (Carlsbad, CA, US). The MGARP promoter (23 kb) was
amplified by PCR using the following primers: 59 GCT AAG
CTT ATT CCA CAG AGA GGC TGA GAG-39 and 59-TAT
GGA TCC GGA CTT TCT TAA CTG CTT GCC-39. The
cloned MGARP promoter was digested with BamHI and HindIII
and inserted into the pGL3-basic (Promega, Madison, WI, USA)
and pDsRed-Express-1 (Clontech, Palo Alto, CA, USA) vectors to
generate the pGL3-MGARP, pGL3-(23 kb) and pDsRed-
MGARP reporters. The MGARP promoter from the pGL3-
(23 kb) plasmid was digested by XbaI and HindIII to obtain two
Sp1 binding regions that were subcloned into pGL3-basic and
pDsRed-Express-1 to form corresponding reporters. The region
(2150/0 bp) encompassing both GC-boxes was named Box1&2;
the region (2150/240 bp) containing the far proximal GC-Boxes
was named Box1; and the region (239/0 bp) containing the near
proximal GC-Boxes was named Box2. To obtain the promoter
regions with or without an Sp1-binding site, more oligos were
synthesized and used for amplification (Table S1) to generate the
indicated reporter plasmids. The plasmid containing the deletion
of Box1 (DEL1) was named pGL3-DEL1; the plasmid containing
the deletion of Box 2 (DEL2) was named pGL3-DEL2; and the
plasmid containing the deletion of both BOX1 and BOX2 (DEL
1+2) was named pGL3-DEL1&2. The reporter clones were
verified by sequencing. The two GC-Boxes were also isolated and
cloned separately or jointly to generate the indicated reporters,
with a SalI site that exists between two Sp1 binding motifs used for
the separation of the two Boxes. As the result, the following
reporters were generated: pGL3-Box1&2, pGL3-Box1 and pGL3-
Box2. For knockdown of Sp1, four short hairpin oligos targeting
the 630 position (upper strand sequence: 59-GAT CCA CCA ACA
GAT TAT CAC AAA TTC AAG AGA TTT GTG ATA ATC
TGT TGG TTT TTT TGG AAA-39; lower strand sequence: 59-
AGC TTT TCC AAA AAA ACC AAC AGA TTA TCA CAA
ATC TCT TGA ATT TGT GAT AAT CTG TTG GTG-39) and
1722 position (upper strand sequence: 59-GAT CCG TAC ATG
ATG ACA CAG CAG GTT CAA GAG ACC TGC TGT GTC
ATC ATG TAT TTT TTG GAA A-3; lower strand sequence: 59-
AGC TTT TCC AAA AAA TAC ATG ATG ACA CAG CAG
GTC TCT TGA ACC TGC TGT GTC ATC ATG TAC G-39)
of the Sp1 gene were synthesized and cloned into pSilencer,
generating two shRNA expression plasmids, 630-RNAi and 1722-
RNAi, respectively. Their effectiveness was tested by western
blotting (Text S2). The Sp1 expression plasmid was a kind gift
from Dr. Jon Horowitz (Department of Molecular Biomedical
Sciences, North Carolina State University, College of Veterinary
Medicine) and was sent to us with the ERa plasmid by Dr.
Shaoyong Chen (BIDMC, Harvard Medical School, USA). The
Sp1 antibody was purchased from Millipore (Upstate, MA, USA).
Cell Culture, Transfection, Luciferase (Luc) Assay and Red
Fluorescence Protein Detection
HEK-293T cells were obtained from the Cell Resource Center
(IBMS, CAMS/PUMC, BJ, China) and were grown in DMEM
(Hyclone, Logan, UT, USA) supplemented with 10% fetal bovine
serum (FBS) (ExCell Biology, SH, China) and penicillin/strepto-
mycin. The reporters were transfected, as indicated, into HEK-
293T cells using Vigofect reagent (Vigorous Biotechnology, BJ,
China) according to the manufacturer’s protocol. After 6 hours,
the medium was replaced with DMEM containing 10% FBS and
antibiotics. 72 hours post transfection, cells were harvested for Luc
assay using the Luc assay system (Vigorous Biotechnology, BJ,
China), and the activity of Firefly luciferase values were
normalized to that of the Renilla luciferase.
Semiquantitative RT-PCR Analysis
Total RNA from HEK-293T cells transfected with scramble or
specific RNAi (6 mg/well for 6-well plate) was extracted using
TRIzol (Invitrogen, Carlsbad, California, US). Reverse transcrip-
tion was performed using 1 mg of total RNA with the RNA PCR
Kit of AMV Ver.3.0 (Takara, DL, China). Primer sequences for
MGARP transcripts were 59-ATGTATCTCCGCAGGGCGGT-
39 and 59-CCCTTTGAGCCGAAGCAGC-39 and for Sp1
transcripts, they were 59-CTAAGTCCTAGCTAAGTAT-
CAGG-39 and 59-AGAGGATGACAGACTTAGGAAGG-39.
The thermal cycling profile for the PCR reaction was the
following: 95uC for 30 s, 58uC for 30 s and 72uC for 1 min for
25 PCR cycles. Products were resolved with 1.5% agarose gels.
Electrophoretic Mobility Gel Shift Assay (EMSA)
HEK-293T and Y-1 mouse adrenocortical cells (Y1) (Cell bank
of Chinese Academy of Sciences, SH, China) were cultured in
60 mm plates in DMEM or RPMI 1640 containing 10% FBS,
transfected with the Sp1 plasmid, and then grown for additional
48 hours. The nuclear proteins were extracted and the total
protein concentration of nuclear extracts was determined using the
BCA assay (Pierce, Rockford, IL, USA). The values obtained were
subsequently used for normalization. The oligonucleotides corre-
sponding to the proximal GC boxes in the MGARP promoter
were synthesized, annealed and 39 end-labeled using the Biotin Kit
(Invitrogen, Carlsbad, CA, US). LightShift Chemiluminescent
EMSA kit (Thermo, Rockford, IL, USA) was used with 20 ml
MGARP Is Regulated via Tandem Sp1 Elements
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of Poly (dINdC) and crude nuclear extracts of HEK-293T and Y1
cells. 4 pmol of unlabeled competitor oligonucleotides, mutated
unlabeled competitor oligonucleotides and 20 fmol of labeled
probe were applied and incubated on ice for 10 min. The
sequence of biotin labeled probe corresponding to the Sp1 binding
region is 59-TCCCGGGGGCCG- CGGAGGCGGGG
CTGGAT-39 (BOX1). The Sp1 antibody (07-645, Upstate, MA,
USA) reaction with nuclear proteins was carried out for 10 min
before the probe reaction was initiated. DNA-protein complexes
were loaded onto a 5% SDS-PAGE gel for blotting. Analysis of
ERa interaction with the MGARP promoter was carried out
similarly.
ChIP Assay
ChIP was performed on HEK-293T cells using the Chromatin
Immunoprecipitation Assay Kit (Upstate, MA, USA) according to
the manufacturer’s instructions. Briefly, 4610
6 cells were cross-
linked by incubation with formaldehyde at a final concentration of
1% for 10 min at room temperature. The reaction was then
quenched by glycine. The cells were subsequently washed twice
with cold PBS, lysed in 400 ml SDS lysis buffer containing protease
inhibitor cocktail II and subjected to sonication (7610 sec). Then
soluble chromatin was incubated with IgG and agarose for 1hour
to pre-clear the chromatin. Immunoprecipitations were carried
out by incubating with anti-Sp1 antibody (07-645, Upstate, MA,
USA), anti-RNA polymerase II (Pol II) antibody (05-623B,
Upstate, MA, USA) or negative control IgG (sc-2027, Santa
Cruz, CA, USA) overnight at 4uC with rotation. Agarose beads
were then added for a one-hour incubation at 4uC, followed by
washing. The crosslink was reversed by heating overnight at 65uC,
followed by treatments with RNase A for 30 min at 37uC and
proteinase K for 2 hours at 45uC. The DNA was purified by
phenol extraction and ethanol precipitation. The PCR reactions
were carried out for 33 cycles with the following parameters: 94uC
for 20 s, 56uC for 30 s, and 72uC for 30 s. The sequences of
primers spanning the proximal GC-boxes (BOX1&2) of the
MGARP gene promoter were sense, 59-AGGAGTTACATT-
CAGTGGTACAGAA-39; and antisense, 59-CCTTCCACAGA-
GAGGCTGAGAGCCT-39. The expected amplicon was 257 bp,
and the PCR product was resolved by gel electrophoresis on 2.0%
agarose.
Statistical Analysis
Multiple groups (at least 3 replicates for each test) of data for
parallel reporter studies were analyzed based on the ratio of the
firefly luciferase value to that of the renilla luciferase, using the
SigmaPlot software for one Way ANOVA to generate specific P
values. A value of P,0.05 was considered to be significant.
Results
Defining the Promoter Region of the Human MGARP
Gene
After performing a BLAST search of the NCBI database, the
MGARP gene was found to be located on the minus strand of the
Homo sapiens chromosome 4 genomic contig (The accession
number of this genomic contig in GenBank is NW-922217.)
Additionally, a 210 kb region upstream of the TSS was submitted
for prediction of promoter properties. A typical CpG island, but
no obvious TATA box, was identified in the proximal 23k b
region of the first exon (Figure 1A). For further definition, we
compared the 23 kb promoter regions of three species and, as
shown in Figure 1A, there are some key features of the promoter
those are highly conserved among Homo sapiens (Human), Pan
troglodytes (Chimpanzee) and Macaca mulatta (Macaque). Particularly,
these promoters share marked enrichment of a CpG island in the
proximal region (Figure 1A). Further analysis of the 23 kb human
MGARP promoter region for binding elements revealed putative
binding sites for the following 13 transcription factors: AM-1a,
CdxA, Lyf-1, SRY, Nkx-2, Ap-2, MZF1, T-Ag, UCE.2, GCF,
Sp1, APRT and EARLY-SEQ1 (Figure 1B). Among them, Sp1
binding sites were identified at high frequencies and were
particularly enriched in the proximal region that is highly
conserved and GC-rich (Figure 1B). The two potential Sp1
binding motifs, (,220 bp to ,260 bp) and (0 ,220 bp), were
located in close proximity to the TSS, each containing two Sp1
binding elements (Figure 1B). These two motifs were identified as
two GC-boxes, a far proximal GC-box (,220 bp to ,260 bp;
Box1) and a near proximal GC-box (0 ,220 bp; Box2).
To verify the activity of the putative MGARP promoter, the
3 kb DNA region upstream of the first exon of MGARP (23 kb)
was cloned into the pGL3-basic and pDsRed-Express-1 vectors to
generate reporters for Luc analysis (pGL3-MGARP) and red
fluorescence reporter (pDsRed-MGARP), respectively. The results
demonstrated that the cloned MGARP promoter had basal
activity in both reporter systems (Figure 1C, Figure S1).
Sp1 Enhances MGARP Promoter Activity and Mediates
MGARP Transcription
The above analysis indicated that Sp1 is a candidate
transcriptional factor for MGARP gene expression. To clarify
this finding, the pGL3-MGARP and pDsRed-MGARP reporters
driven by the 23 kb MGARP-promoter were each cotransfected
into HEK-293T cells, with increasing doses of Sp1 expression
plasmids. As shown in Figure 2A and 2B, both Luc and
fluorescence protein assay results showed that co-expression of
Sp1 significantly increased the MGARP promoter activity in a
dose-dependent manner. To further confirm the involvement of
Sp1 in MGARP promoter activation, we designed two oligo pairs
that specifically targeted the Sp1 gene and generated two shRNA
expression vectors, 630-RNAi and 1722-RNAi. As shown by
western blotting, both 630-RNAi and 1722-RNAi could effectively
reduce the expression of endogenous and exogenous Sp1, as
compared to the control (pSilencer-scramble plasmid) (Figure 2C).
Significantly, cotransfection of either 630-RNAi or 1722-RNAi
with the pGL3-MGARP reporter led to a remarkable decrease in
luciferase activity, in both the absence or presence of co-expressed
Sp1 (Figure 2D). Moreover, RT-PCR results showed that down-
regulation of Sp1 by specific RNAi could reduce the endogenous
MGARP gene expression (Figure 2E). These findings demonstrate
that Sp1 is a critical transactivator for transcriptional activation of
the MGARP promoter.
Sp1 Activates the MGARP Promoter via Two GC-rich
Motifs
As detailed above, two GC-boxes were identified in the
proximal MGARP promoter centered at ,0 bp and ,260 bp,
respectively. Each GC-box is clustered with two Sp1 binding
elements. To clarify which GC rich motif is essential for Sp1-
mediated regulation, several reporter constructs were generated
with or without the GC-boxes (Figure 3). Results of the reporter
assay indicated that the following promoters carried basal activity:
pGL3-MGARP (23 kb), pGL3-Box1&2, pGL3-Box1 and pGL3-
DEL2; and that the luciferase activity derived from these
promoters was significantly enhanced by co-expressed Sp1.
However, the following reporters suggested transcriptional silence
MGARP Is Regulated via Tandem Sp1 Elements
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pGL3-DEL1&2 and pGL3-DEL1 (Figure 3). These findings
indicate that GC-Box1 plays a dominant role to mediate Sp1-
dependent transactivation of the MGARP promoter, and it
requires both GC-Boxes to achieve full transcriptional activity.
Additionally, the pGL3-Box1&2 promoter produced comparable
(or slightly higher) luciferase activity when compared to the full-
length pGL3-MGARP promoter (pGL3-(23 kb)) (Figure 3), sug-
gesting that Sp1 is the predominant transcriptional activator for
the 23 kb proximal promoter region.
As a complementary approach, a similar test was carried out
with co-expressed Sp1 and pDsRed-MGARP promoter (23 kb),
pDsRed-Box1&2, pDsRed-Box1 or pDsRed-Box2 reporters. The
intensity of the red fluorescence showed a similar pattern of these
promoters’ activities as compared to that of the Luc assay, in the
absence and presence of co-expressed Sp1 (Figure S2).
Together, these findings indicate that substantial activation of
the MGARP promoter critically depends on Sp1 and the proximal
150-bp region (2150/0 bp) that contains two GC-rich boxes, and
that a synergistic interaction between the two Sp1 binding motifs is
required for effective promoter activation.
Sp1 Binds to the GC Boxes of the MGARP Promoter
Next, we performed an EMSA to examine whether these GC
boxes mediated the interaction of Sp1 with the MGARP promoter
DNA backbone. Biotin-labeled short DNA oligos corresponding to
Box1 were synthesized and annealed. Nuclear extracts from Sp1-
overexpressed HEK-293T cells were incubated with the probe or
the plain buffer as a control. As shown in Figure 4A, a shifted band
was observed in the presence, but not the absence, of nuclear
extracts, and the intensity of the band was associated with the
concentrations of the extracts (Lane 2 and 3 in Figure 4A).
Significantly, the shifted bands were eliminated when incubated
with 200-fold excess unlabeled probe, but the mutated-unlabeled
probe had no effect, indicating the specificity of Sp1 binding to the
GC boxes of the MGARP promoter (Lane 4 and 5 in Figure 4A).
At the same time, we attempted to super-shift the band by adding
Sp1 specific antibody. After addition of the antibody to the
reaction mixture, a super-shifted band was produced, and the
amount of the corresponding shifted band was reduced (Lane 6 in
Figure 4A).
Similarly, we performed an additional EMSA using HEK-293T
cells subjected to Sp1-overexpression or RNAi-mediated Sp1
down-regulation. The results indicated that the endogenous Sp1 in
HEK-293T cells could bind to the GC-boxes (control), overex-
pression of Sp1 markedly enhanced the intensity of the shifted
band, and knockdown of Sp1 substantially reduced the binding,
suggesting that this shifted band was Sp1-mediated (Figure 4B).
Since the HEK-293T cells were reported to have a relationship
to neurons [27], and MGARP was demonstrated to be expressed
in neurons and Y1 cells [4,7], we examined and compared the
expression of Sp1 and MGARP in HEK-293T and Y1 cells by
Western blot. The results indicated that that both HEK-293T and
Y1 cell could express endogenous Sp1 and MGARP proteins
(Figure S3). The HEK-293T cells expressed more Sp1 and less
MGARP while Y1 cells expressed less Sp1 and more MGARP
proteins. To verify the above findings in an independent cellular
system, Y1 cells were used because they express abundant
MGARP protein and may contain a substantial amount of
competent cofactors of Sp1 molecules that assist Sp1 in regulation
of MGARP transcription. As shown in Figure 4C, a similar
observation in binding was made by EMSA using Y1 cell nuclear
Figure 1. Bioinformatics analysis of the MGARP promoter. A. Promoter analysis comparing the 23 kb upstream region of the MGARP gene
between three species (Homo sapiens, Pan troglodytes and Macaca mulatta). B. A summarized display of the 23 kb upstream region in the human
MGARP promoter with predicted promoter and transcription factor (TF) binding sites. C. Luciferase (Luc) reporters driven by the 3 Kb MGARP
promoter (pGL3-(23 kb)) and the promoter-less control (pGL3-Basic) were transfected into HEK-293T cells and analysis was carried out as described
in Materials and Methods. *** represents p,0.001 and
#represents p.0.05 (no significant difference).
doi:10.1371/journal.pone.0050053.g001
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effectively bind the GC boxes of the MGARP promoter in
different kinds of cell lines. However, with the addition of the
antibody to the reaction mixture of Y1 cell nuclear extract, the
super-shifted band disappeared (Figure 4C). This may indicate
that an interaction of Sp1 with this antibody changed the
molecular behaviors of Sp1, either by structurally altering the
Sp1 protein, or by blocking the accessibility of the oligos. In any
case, the test with the antibody indicated that the shifted bands
specifically depend on Sp1.
To further validate the binding between Sp1 and GC-Boxes
in vivo, we performed Chromatin Immunoprecipitation (ChIP)
assay using HEK-293T cells. The results demonstrated that
Sp1specifically bound to the GC-box locus on the endogenous
MGARP promoter, but not to the control GAPDH locus
(Figure 5). Together, our results suggest that Sp1 proteins directly
bind to the proximal GC-rich region of the MGARP promoter.
Sp1 and ER Synergistically Stimulate MGARP Promoter
Activity
It was reported that ERa interacts with Sp1 and they act
synergistically to activate downstream genes [19,28]. Considering
that MGARP protein expression can be up-regulated by estrogens
[5], we reasoned that ERa might be able to regulate the
transcription of MGARP or coordinate with Sp1 in the activation
of the MGARP promoter. This hypothesis was first tested by co-
Figure 2. MGARP promoter activation is mediated by Sp1. A. Luc assay shows that Sp1 mediates the MGARP promoter activity in a dose-
dependent manner. HEK-293T cells were co-transfected with pGL3-(23 kb) and the increasing doses of Sp1 plasmids for Luc assay. B. Similarly, the
pDsRed-MGARP(23 kb) reporter and several doses of Sp1 plasmids were co-transfected into HEK-293T cells to examine the expression of red
fluorescent protein at 72 hours post transfection. C. Western blotting shows that knockdown of Sp1 with Sp1-specific RNAi (630-RNAi and 1722-RNAi)
reduces the expression of both endogenous and exogenous Sp1. The scramble-RNAi and RNAi targeting GFP were used as control. D. Luc assays to
determine the effect of Sp1 knockdown on MGARP promoter activity. *** represents p,0.001 (E) Semiquantitative RT-PCR analysis confirms that
knockdown of Sp1 reduces the MGARP gene expression. Similarly, HEK-293T cells were transfected with control and Sp1-specific RNAi and harvested
for semiquantitative RT-PCR analysis of MGARP messages expression.
doi:10.1371/journal.pone.0050053.g002
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increasing concentrations of the ERa expression plasmids. The
Luc assay results demonstrated that ERa could dose-dependently
enhance MGARP transcriptional activity, indicating that this
23 kb upstream region may either contain non-classic ER-
binding site(s) or engage with ERa-interacting transactivator(s),
including endogenous Sp1 (Figure 6A). Importantly, co-expression
of Sp1 with ERa can further increase ER-induced reporter
activity, demonstrating significant synergistic effects on the
MGARP promoters (Figure 6B). In addition, the synergistic effect
was different for distinct regions of the MGARP promoter, with
the promoters restricted to the GC Box1&2 and Box1 producing
the most greatest synergy, further supporting that it is primarily
mediated by Sp1 (Figure 6B). Since ERa can be activated by its
Figure 3. GC-box1 plays a major role in MGARP promoter activation and both GC-boxes are required for full transactivation. The
Luc reporters driven by the full-length MGARP promoter (23 kb) were transfected into HEK-293T cells, as compared to various promoter truncates
either missing the GC-Boxes or expressing the GC-Boxes alone, without or with co-transfection of Sp1 plasmids (10 ng) as indicated. Luc activity was
examined at 72 hours post transfection. *** represents p,0.001 and
#represents p.0.05 (no significant difference).
doi:10.1371/journal.pone.0050053.g003
Figure 4. EMSA test indicates that Sp1 directly binds to the GC-boxes of the MGARP promoter. For the EMSA analysis, nuclear extracts
(Nu) from HEK-293T or Y1 cells were incubated with Biotin-labeled oligonucleotides (Biotin-probe) spanning the GC-rich region (BOX1) of the MGARP
promoter (23 kb). Competition reactions were performed with 200X of unlabeled cold competitor (cold), 200X of mutated-labeled competitors (mu)
or Sp1 antibody (2 mg). The following cell lines were used: non-transfected or Sp1-overexpressed HEK-293T cells (A), non-transfected, Sp1-
overexpressed, or 630-RNAi transfected HEK-293T cells (B), and Y1 cells (C).
doi:10.1371/journal.pone.0050053.g004
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activity of ERa under the stimulation of estrogen. Our results
indicated that estrogens could modestly enhance the transactiva-
tion activity of ERa on the MGARP promoter and markedly
enhance the promoter activity in the presence of exogenous Sp1,
while minimal effects were recorded on the control vector
(Figure 6C). In contrast, in both the absence and presence of
exogenous Sp1, knockdown of Sp1 significantly reduced the
activation function of ERa on the MGARP promoter (Figure 6D).
Furthermore, in ERa-transfected HEK-293T cells, estrogens
could increase endogenous MGARP expression, while down-
regulation of Sp1 led to a reduction in endogenous MGARP
mRNA expression, in the absence and presence of estrogens
(Figure 6E). Together, these findings demonstrate that Sp1 and
ERa up-regulate MGARP promoter activity in a synergistic
manner and that ERa may act as a co-activator for Sp1 to regulate
MGARP promoter activity.
Discussion
Gene transcription in eukaryotic organisms depends on the
interplay between transcription factors and regulatory elements in
promoters. Transcription is regulated by chromatin-interacting
factors, which bind to their specific DNA recognition sequences
[29]. Sp1 is a general transcription factor driving gene expression
in early development [30,31], containing a zinc finger motif that
mediates binding to DNA with the consensus sequence 59-(G/
T)GGGCGG(G/A)(G/A)(C/T)-39 (GC box element). We dem-
onstrated that the region spanning -150 to 0 bp of the MGARP
promoter fragment has basic promoter properties and contains
multiple Sp1 binding sites that converge into two GC-Boxes. The
enrichment of Sp1 binding motifs would potentially allow for the
fine-tuning of transcription by this factor. Indeed, using a reporter
assay we found that the MGARP promoter could be stimulated by
Sp1 in a dose-dependent manner, suggesting that Sp1 functions as
a limiting factor. In addition, integration of each GC-Box into
basic reporters resulted in minimally active transcription and
combining two GC-Boxes resulted in full activation of the
promoter, indicating a synergistic mechanism between these two
motifs. The findings that each individual GC-Box carries Sp1-
activated promoter function and that a 2150 bp proximal region
is responsible for a significant part of MGARP promoter activity
demonstrate that Sp1 is a dominant transactivator for MGARP
expression. Comparing these two specific GC-rich Boxes, we
propose that Box1 plays a major role in Sp1 transcriptional
activity and that Box2 works cooperatively with Box1 to achieve
full transactivation.
Our previous study showed that MGARP is highly expressed in
the ovary, testis, retina and adrenal gland tissues, and its
expression is under the regulation of the HPG axis [5]. MGARP
has also been shown to be up-regulated by estrogens and its
expression level correlates with the level of estrogens in the ovary
during the estrous cycle [5]. These findings imply that MGARP
functions in steroidogenesis and that MGARP is modulated by
steroids [5]. In our computational promoter analysis, we did not
identify classic ERa binding element(s) in the 23 kb proximal
region; however, there still exists a possibility for direct ERa
engagement with the proximal or distal promoter via non-classical
binding site(s). In any case, here we demonstrate that ERa can
stimulate the MGARP promoter in a dose-dependent manner. We
further determined that ERa co-expression can stimulate Sp1-
mediated promoter activation and this synergy can be further
enhanced by estrogens. This suggests the existence of cross-talk
between ERa and Sp1 at this gene locus, consistent with the
reported findings that estrogens can enhance ERa-Sp1 interac-
tions [32,33]. Moreover, the critical dependence of ERa
stimulatory effects on the GC Boxes and Sp1 indicated that Sp1
plays a dominant role in this synergistic interaction. The
magnitude of ERa stimulatory effects on the MGARP promoter
may depend on the ratio and sufficiency of each of the components
in the systems, the availability of Sp1 and estrogens, and the
structural composition of the promoter. The isolated mini
MGARP promoter (tandem Sp1 elements) has a higher basal
activity and more substantial response to ERa than the full-length
23 kb promoter, indicating that there are other factors in the
23 kb promoter contributing to the transcriptional regulation and
the effects of ERa. Together, these findings suggested that ERa
may potentiate MGARP transcription by serving as a co-activator
for Sp1.
Sp1 is an abundant nuclear protein in most cells, but Sp1
protein levels showed marked differences during development and
varied in different cell types [14,34]. Sp1 protein expression was
highest in the spermatids of sexually mature animals [34]. Sp1
knockout embryos are retarded in development, show a broad
range of abnormalities, and die around day 11 of gestation [21].
As a classical nuclear and steroid receptor, ERa has profound
implications in reproductive tract development and neuronal and
vascular function [35]. Adult ER knockout mice exhibit several
abnormalities and deficiencies, including phenotypic syndromes
that result in infertility in both sexes [36]. More importantly, it has
been well-documented that Sp1 and ERa synergistically regulate
down-stream gene expression [32,37–39], and their physical
interaction enhances Sp1-DNA binding [33]. Our present data
demonstrate that estrogen and ERa synergistically enhanced the
MGARP promoter activation by Sp1. These findings provide
explanations to our reported observations that MGARP was
highly enriched in steroidogenic tissues and the neuronal/visual
system and that estrogens up-regulate MGARP expression [4,5,7].
The physiological defects that resulted from targeted disruption of
the ER gene [36] may be mediated, at least in part, by the
deficiency in ER-Sp1 complex formation and reduction in
MGARP expression that may cause aberrant steroid hormone
synthesis, ultimately leading to diverse animal abnormalities,
especially infertility.
Although reporter analysis of these two GC boxes indicated a
prominent role for the 150-bp proximal region in MGARP
Figure 5. ChIP analysis indicates that Sp1 binds to MGARP
promoter in vivo. ChIP was performed as described in the Materials
and Methods. HEK-293T cells and antibodies for RNA polymerase II (Pol
II) and Sp1 were used, with IgG as control. The immunoprecipitated
chromatin was amplified by PCR with primers specific for the GC-rich
region (BOX1&2) of the MGARP promoter (23 kb), with GAPDH locus as
control. M: DNA Marker.
doi:10.1371/journal.pone.0050053.g005
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PLOS ONE | www.plosone.org 7 November 2012 | Volume 7 | Issue 11 | e50053Figure 6. ERa up-regulates the transcription of the MGARP promoter and acts in synergy with Sp1 to activate MGARP
transcriptional activity. A. pGL3-(23 kb) reporter and different doses of ERa expression plasmid were co-transfected into HEK-293T cells to
determine the dose-dependent manner of ERa in regulating the MGARP promoter by luciferase assay. B. The functional synergy between Sp1 and
ERa was determined by cotransfection of the full-length MGARP promoter (23 kb) or various promoter truncates with or without Sp1 plasmids for
Luc assay as indicated. C. The synergystic transactivation activity of ERa and Sp1 under the stimulation of estrogens. The HEK-293T cells were treated
with or without 10 nM of estradiol (E2) for 24 hours post transfection of pGL3-(23 kb) and ERa. Subsequently, the Luc assay was performed at 72
hours post transfection. D. Knockdown of Sp1 diminishes the activation function of ERa on MGARP promoter. HEK-293T cells were co-transfected
with pGL3-(23 kb) reporter and ERa, together with Sp1-specific RNAi (630-RNAi or 1722-RNAi) or control RNAi, in the absence or presence of
exogenous Sp1. *** represents p,0.001 and
# represents p.0.05 (no significant difference). E. RT-PCR shows that down-regulation of Sp1 with Sp1-
specific RNAi (630-RNAi or 1722-RNAi) results in a reduction in endogenous MGARP mRNA expression in HEK-293T cells when stimulated by 10 nM
E2. The cells were treated with or without 10 nM E2 for 24 hours post transfection and total RNA was harvested at 72 hours post transfection for
semiquantitative RT-PCR analysis.
doi:10.1371/journal.pone.0050053.g006
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contribute to the transcription of the endogenous MGARP gene.
As shown in Figure 3, the 23 kb promoter responds to the
transfected Sp1 less than the minimal GC-Boxes (2150 bp),
indicating that additional factors (or suppressors) may exist in this
region and are involved in regulating the MGARP promoter
activity. By bioinformatics analysis, we identified multiple chro-
matin-associated transcriptional factors that potentially bind to the
promoter in the flanking regions of the GC-Boxes. The
contribution of these proteins to MGARP transcription needs to
be verified and may be important. For example, the 23k b
promoter region contains multiple binding motifs for SRY, an
androgen receptor co-repressor [40]. SRY is a sex-determining
gene on the Y chromosome, and mutations in this gene can cause
abnormal sex development [41–43]. The regulation of MGARP
by SRY, if validated, would suggest a pathway by which the
androgen receptor modulates MGARP expression and in turn,
MGARP may also mediate the biological and physiological effects
of SRY. Together, our data suggest that the proximal promoter is
Sp1-centered and the dependence of Sp1 for endogenous
MGARP expression indicates that Sp1 is one major transactivator
for the MGARP promoter, and additional regulatory factors may
participate in regulation of the whole gene promoter.
In summary, we defined Sp1 as a major MGARP transactivator
in the proximal MGARP promoter and identified two GC boxes
in this region that mediate the transactivation of MGARP gene by
Sp1. Sp1-driven transcription can be further enhanced by ERa,
suggesting that the functional synergy between ER and Sp1
mediates the stimulating effect that estrogen was shown to have on
MGARP transcription, providing a molecular mechanism for
MGARP transcriptional regulation by steroids.
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